FR2360304B1 - - Google Patents

Info

Publication number
FR2360304B1
FR2360304B1 FR7723939A FR7723939A FR2360304B1 FR 2360304 B1 FR2360304 B1 FR 2360304B1 FR 7723939 A FR7723939 A FR 7723939A FR 7723939 A FR7723939 A FR 7723939A FR 2360304 B1 FR2360304 B1 FR 2360304B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7723939A
Other versions
FR2360304A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2360304A1 publication Critical patent/FR2360304A1/fr
Application granted granted Critical
Publication of FR2360304B1 publication Critical patent/FR2360304B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
FR7723939A 1976-08-04 1977-08-03 Agents antiglaucome Granted FR2360304A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/711,749 US4136183A (en) 1976-08-04 1976-08-04 Benzopyranopyridines as antiglaucoma agents

Publications (2)

Publication Number Publication Date
FR2360304A1 FR2360304A1 (fr) 1978-03-03
FR2360304B1 true FR2360304B1 (fr) 1981-07-31

Family

ID=24859354

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7723939A Granted FR2360304A1 (fr) 1976-08-04 1977-08-03 Agents antiglaucome

Country Status (7)

Country Link
US (1) US4136183A (fr)
JP (1) JPS5318584A (fr)
CA (1) CA1084841A (fr)
DE (1) DE2735046A1 (fr)
FR (1) FR2360304A1 (fr)
GB (1) GB1592617A (fr)
ZA (1) ZA774489B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025385A1 (de) * 1980-07-04 1982-01-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue tricyclische arylether, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
FR2645021A1 (fr) * 1989-03-30 1990-10-05 Sanofi Sa Utilisation d'un agoniste potassique dans le traitement du glaucome
US20210278416A1 (en) 2017-05-09 2021-09-09 The Broad Institute, Inc. Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493579A (en) * 1967-05-29 1970-02-03 Little Inc A 1,4-ethano-5h-(1)benzopyrano (3,4-b)pyridines
US3991194A (en) 1971-12-27 1976-11-09 Sharps Associates Heterocyclic esters of benzopyranopyridines
US3838158A (en) * 1972-05-08 1974-09-24 Sharps Ass Dialkylamino ethers of benzopyranopyridines
US3787424A (en) * 1972-05-08 1974-01-22 Sharps Ass Dialkylamino esters of benzopyranopyridines
US3798326A (en) * 1972-08-24 1974-03-19 Sharps Ass 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1)benzopyrano(3,4-d)pyridine as an anti-hypertensive agent
US3795736A (en) * 1972-08-24 1974-03-05 Sharps Ass 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1) benzopyrano(3,4-d)pyridine as an analgesic agent
US3777028A (en) * 1972-08-24 1973-12-04 Sharps Ass 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1)-benzopyrano(3,4-d)pyridine as an anti-diarrheal agent
US3961057A (en) * 1973-03-21 1976-06-01 Warner-Lambert Company Benzopyrano(3,4-C)pyridine bronchodilators
US3901926A (en) * 1973-04-02 1975-08-26 Abbott Lab Alkylphenyl benzopyrans
US3932432A (en) * 1973-04-02 1976-01-13 Abbott Laboratories Alkylphenyl benzopyranopyridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3905969A (en) * 1974-01-17 1975-09-16 Sharps Ass Heterocyclic esters of 5H-{8 1{9 benzopyrano{8 3,4-b{9 pyridines
US3962448A (en) * 1974-03-11 1976-06-08 Smithkline Corporation 8-Alkyl and alkenyl-10-hydroxy-5H[1]benzopyranopyridine derivatives having polyphagic activity
US3896137A (en) * 1974-03-11 1975-07-22 Smithkline Corp 8-alkyl and alkenyl-10-hydroxy-5h(1)benzopyranopyridine derivatives and uses thereof
US3984546A (en) * 1974-12-19 1976-10-05 Warner-Lambert Company Substituted benzopyrano [3,4-c]pyridines for the treatment of bronchial asthma
US3962266A (en) * 1974-12-19 1976-06-08 Warner-Lambert Company Novel substituted benzopyranopyridine

Also Published As

Publication number Publication date
FR2360304A1 (fr) 1978-03-03
CA1084841A (fr) 1980-09-02
US4136183A (en) 1979-01-23
AU2750877A (en) 1979-02-08
DE2735046A1 (de) 1978-02-09
JPS5318584A (en) 1978-02-20
ZA774489B (en) 1978-06-28
GB1592617A (en) 1981-07-08

Similar Documents

Publication Publication Date Title
DE2709609C2 (fr)
FR2372522B1 (fr)
DE2621606C2 (fr)
CH637799GA3 (fr)
FR2355584B1 (fr)
FR2360304B1 (fr)
DE2641942C2 (fr)
DE2603057C2 (fr)
FR2355010B1 (fr)
JPS5332129U (fr)
JPS5356824U (fr)
JPS5419415Y2 (fr)
JPS5512009Y2 (fr)
CS187793B1 (fr)
JPS534240U (fr)
JPS52128438U (fr)
JPS53622U (fr)
JPS5370462U (fr)
JPS52130855U (fr)
JPS5330010U (fr)
JPS52126095U (fr)
JPS5322673U (fr)
DD127361A1 (fr)
DD125953A1 (fr)
DD122828A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse